S. Claiborne Johnston

59.0k citations

338 papers · 35.8k indexed · 15 hit papers · h-index 83

Internal Medicine top 0.05%
- Venous Thromboembolism Diagnosis and Management 44
Neurology top 0.02%
- Intracranial Aneurysms: Treatment and Complications 48
- Traumatic Brain Injury and Neurovascular Disturbances 45
Rehabilitation top 0.02%
Epidemiology top 0.02%
- Acute Ischemic Stroke Management 169
Cardiology and Cardiovascular Medicine top 0.05%
- Antiplatelet Therapy and Cardiovascular Diseases 79
- Atrial Fibrillation Management and Outcomes 42
Pulmonary and Respiratory Medicine
- Cerebrovascular and Carotid Artery Diseases 97
Economics and Econometrics
- Health Systems, Economic Evaluations, Quality of Life 26

Co-authors: Stephen Sidney Daryl R. Gress Heather J. Fullerton Karen L. Furie Lee H. Schwamm Bruce Ovbiagele J. Claude Hemphill Anthony Kim
Cited by: Internal Medicine Neurology Rehabilitation
Journals: New England Journal of Medicine (5 papers)Proceedings of the National Academy of Sciences (1 paper)The Lancet (2 papers)
Partner nations: United States United Kingdom China

In The Last Decade

S. Claiborne Johnston

328 papers receiving 34.7k citations

Hit Papers

15 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2020 New England Journal of Medicine
2018 New England Journal of Medicine
2015 Stroke
2015 Stroke
2014 Stroke
2013 Stroke
2013 New England Journal of Medicine
2011 Circulation
2010 Stroke
2009 The Lancet Neurology
2009 Stroke
2007 The Lancet
2006 Stroke
2005 Neurology
2001 Stroke

Peers

Countries citing papers authored by S. Claiborne Johnston

Since Specialization

Citations

This map shows the geographic impact of S. Claiborne Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Claiborne Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Claiborne Johnston more than expected).

Fields of papers citing papers by S. Claiborne Johnston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Claiborne Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Claiborne Johnston. The network helps show where S. Claiborne Johnston may publish in the future.

Co-authorship network

The 25 scholars most cited alongside S. Claiborne Johnston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Claiborne Johnston Line = papers co-authored together S. Claiborne Johnston links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS) American Heart Journal ·C. Michael Gibson,Maria Cecilia Bahit,Roxana Mehran,Shamir R Mehta,Rasha Al Lamee,Shinya Goto,Jeffrey I. Weitz,Jay Horrow,Elliot S. Barnathan,Robert A. Harrington,Kenneth W. Mahaffey,(unknown),Karen S. Pieper,S. Claiborne Johnston,Graeme J. Hankey,Alexei N. Plotnikov,Danshi Li,Hsiaowei Deng,Philippe Gabríel Steg	2025	4
2	Baseline Stroke Risk and Efficacy of Dual-Antiplatelet Therapy: A Post Hoc Analysis of the POINT Trial Stroke ·Iyas Daghlas,S. Claiborne Johnston,J. Donald Easton,Anthony Kim	2024	0
3	Potential Protein Signatures for Recurrence Prediction of Ischemic Stroke Journal of the American Heart Association ·Zhang Cheng-yi,Yang Liu,Huimin Zhu,Xinying Huang,Cang Guo,Si Cheng,Yuan Meng,Yong Jiang,Xia Meng,S. Claiborne Johnston,Yongjun Wang,Wei‐Na Jin,Fu‐Dong Shi	2024	2
4	Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial BMJ Neurology Open ·Amarjeet Tank,S. Claiborne Johnston,Ritika Jain,Pierre Amarenco,Carl Mellström,Klas Rikner,Hans Denison,Per Ladenvall,Mikael Knutsson,Anders Himmelmänn,Scott Evans,Stefan James,Carlos A. Molina,Yongjun Wang,Mario Ouwens	2023	0
5	Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclerosis (INSPIRES) Stroke and Vascular Neurology ·Ying Gao,Yuesong Pan,Shangrong Han,Weiqi Chen,Jing Jing,Chunjuan Wang,Yingying Yang,Tingting Wang,Xia Meng,Xingquan Zhao,Liping Liu,Hao Li,S. Claiborne Johnston,Pierre Amarenco,Philip M. Bath,Yongjun Wang,Yilong Wang	2023	14
6	Ticagrelor Versus Clopidogrel in Minor Stroke or Transient Ischemic Attack With Intracranial Artery Stenosis: A Post Hoc Analysis of CHANCE‐2 Journal of the American Heart Association ·Chunjuan Wang,Weili Jia,Jing Jing,Xia Meng,Anxin Wang,Qin Xu,Xinmiao Zhang,Yuesong Pan,Xuewei Xie,S. Claiborne Johnston,Philip M. Bath,Jinxi Lin,Yong Jiang,Hao Li,Yilong Wang,Xingquan Zhao,Liping Liu,Zixiao Li,Yongjun Wang,(unknown)	2023	7
7	Colchicine in High-risk Patients with Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3): Rationale and design of a multicenter randomized placebo-controlled trial International Journal of Stroke ·Yongjun Wang,Jiejie Li,S. Claiborne Johnston,Graeme J. Hankey,J. Donald Easton,Xia Meng,Fu‐Dong Shi,Yilong Wang,Xingquan Zhao,Zixiao Li,Liping Liu,Hongqiu Gu,Yong Jiang,Anxin Wang,Yuesong Pan,Jing Jing,Siying Niu,Hao Li	2023	8
8	Effect of Hypertension on Efficacy and Safety of Ticagrelor-Aspirin Versus Clopidogrel-Aspirin in Minor Stroke or Transient Ischemic Attack Stroke ·Anxin Wang,Xia Meng,Xue Tian,S. Claiborne Johnston,Hao Li,Philip M. Bath,Yingting Zuo,Xuewei Xie,Jing Jing,Jinxi Lin,Yilong Wang,Xingquan Zhao,Zixiao Li,Yong Jiang,Liping Liu,Feng Wang,Yanxia Wang,Panbing Huang,Guofang Chen,Yongjun Wang,(unknown)	2022	4
9	Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack Stroke ·S. Claiborne Johnston,Pierre Amarenco,Maria Aunes,Hans Denison,Scott Evans,Anders Himmelmänn,Marianne Jahreskog,Stefan James,Mikael Knutsson,Per Ladenvall,Carlos A. Molina,Sven Nylander,Joachim Röther,Yongjun Wang,(unknown)	2021	11
10	Design of COVID-19 staged alert systems to ensure healthcare capacity with minimal closures Nature Communications ·Haoxiang Yang,Özge Sürer,Daniel Duque,David P. Morton,Bismark Singh,Spencer J. Fox,Remy Pasco,Kelly Pierce,Paul J. Rathouz,Victoria Valencia,Zhanwei Du,Michael Pignone,Mark E A Escott,Stephen I. Adler,S. Claiborne Johnston,Lauren Ancel Meyers	2021	31
11	Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial Clinical Trials ·Scott Evans,Mikael Knutsson,Pierre Amarenco,Gregory W. Albers,Philip M. Bath,Hans Denison,Per Ladenvall,Jenny Jonasson,J. Donald Easton,Kazuo Minematsu,Carlos A. Molina,Yongjun Wang,KS Lawrence Wong,S. Claiborne Johnston	2020	13
12	F2R Polymorphisms and Clopidogrel Efficacy and Safety in Patients With Minor Stroke or TIA Neurology ·Yuesong Pan,Runqi Wangqin,Hao Li,Yilong Wang,Xia Meng,S. Claiborne Johnston,Tabassome Simon,Jinxi Lin,Xingquan Zhao,Liping Liu,David Wang,Yongjun Wang	2020	6
13	Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial International Journal of Stroke ·J. Donald Easton,Hans Denison,Scott Evans,Mikael Knutsson,Pierre Amarenco,Gregory W. Albers,Per Ladenvall,Kazuo Minematsu,Carlos A. Molina,Yongjun Wang,KS Lawrence Wong,S. Claiborne Johnston	2019	6
14	Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial Circulation ·Yilong Wang,Yuesong Pan,Xingquan Zhao,Hao Li,David Wang,S. Claiborne Johnston,Liping Liu,Xia Meng,Anxin Wang,Chunxue Wang,Yongjun Wang	2015	158
15	2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatmentbreakdown → Stroke ·William J. Powers,Colin P. Derdeyn,José Biller,Christopher S. Coffey,Brian L. Hoh,Edward C. Jauch,Karen C. Johnston,S. Claiborne Johnston,Alexander A. Khalessi,Chelsea S. Kidwell,James F. Meschia,Bruce Ovbiagele,Dileep R. Yavagal	2015	1554
16	Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attackbreakdown → Stroke ·Walter N. Kernan,Bruce Ovbiagele,Henry R. Black,Dawn M. Bravata,Marc I. Chimowitz,Michael D. Ezekowitz,Margaret C. Fang,Marc Fisher,Karen L. Furie,Donald Heck,S. Claiborne Johnston,Scott E. Kasner,Steven J. Kittner,Pamela H. Mitchell,Michael W. Rich,DeJuran Richardson,Lee H. Schwamm,John A. Wilson	2014	3347
17	Early Outcomes After Carotid Artery Stenting Compared With Endarterectomy for Asymptomatic Carotid Stenosis Stroke ·Jay Chol Choi,S. Claiborne Johnston,Anthony Kim	2014	28
18	Forecasting the Future of Stroke in the United Statesbreakdown → Stroke ·Bruce Ovbiagele,Larry B. Goldstein,Randall T. Higashida,Virginia J. Howard,S. Claiborne Johnston,Olga Khavjou,Daniel T. Lackland,Judith H. Lichtman,(unknown),Ralph L. Sacco,Jeffrey L. Saver,Justin G. Trogdon	2013	577
19	Pilot Randomized Trial of Outpatient Cardiac Monitoring After Cryptogenic Stroke Stroke ·Hooman Kamel,Babak B. Navi,Lucas Elijovich,S. Andrew Josephson,Alan Yee,Gordon Fung,S. Claiborne Johnston,Wade S. Smith	2012	61
20	Predictors of Rehemorrhage After Treatment of Ruptured Intracranial Aneurysms Stroke ·S. Claiborne Johnston,Christopher F. Dowd,Randall T. Higashida,Michael T. Lawton,Gary Duckwiler,Daryl R. Gress	2007	353

About S. Claiborne Johnston

S. Claiborne Johnston is a scholar working on Internal Medicine, Neurology and Cardiology and Cardiovascular Medicine, having authored 338 papers that have together received 35.8k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (169 papers), Cerebrovascular and Carotid Artery Diseases (97 papers), Antiplatelet Therapy and Cardiovascular Diseases (79 papers), Intracranial Aneurysms: Treatment and Complications (48 papers), Traumatic Brain Injury and Neurovascular Disturbances (45 papers), Venous Thromboembolism Diagnosis and Management (44 papers), Atrial Fibrillation Management and Outcomes (42 papers) and Health Systems, Economic Evaluations, Quality of Life (26 papers). The work is most often cited by research in Internal Medicine (3.7k citations), Neurology (11.4k citations) and Rehabilitation (3.9k citations). S. Claiborne Johnston has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Stephen Sidney, Daryl R. Gress, Heather J. Fullerton, Karen L. Furie, Lee H. Schwamm, Bruce Ovbiagele, J. Claude Hemphill, Anthony Kim, Michael D. Ezekowitz and Ralph L. Sacco. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact